About us
NoToPharm s.r.l. is an academic spin-off from the University of Piemonte Orientale "A. Avogadro" that was started as part of the Discovery project in the 2007.
The company is located at the Bioindustry Park Canavese, Colleretto Giacosa (Turin), and is funded by the Eporgen Venture Spa group.
The enterprise invests in R&D activity in the field of autoimmunity, with particular interest in the discovery and characterization of new biomarkers for the differential diagnosis of autoimmune diseases.
The company's inaugural ceremony will take place on 29th January 2008 at Sala Andromeda-Bioindustry Park Canavese.
A targeted therapy comes from a better diagnosis
News
-
10-14-/10/2008
NoToPharm is present at the 6th International Congress on Autoimmunity, Porto, Portugal -
06-08/03/2008
CEO Michele Mondini holds an oral communication at the Infectious, Rheumatism and Autoimmunity meeting IRA 2008, Milan, Italy -
29/01/2008
Company's inaugural ceremony
Download the program
Read the press release